October 2022
Gut health conditions are among the most prevalent chronic complaints in the general population, yet they remain under-represented in research relative to their impact on quality of life. Symptoms such as bloating, fatigue, constipation, and low mood are frequently dismissed or inadequately managed, and the psychological impact of living with chronic gastrointestinal symptoms is poorly characterised. This study aimed to describe the prevalence, multi-symptom burden, systemic impact, and psychosocial consequences of gut health issues across a large adult sample and to assess existing treatment strategies and their effectiveness. The survey was conducted by DR.VEGAN®, October 2022.
A cross-sectional online survey was administered to 811 adults. Individual-level response data were available for all analyses. The survey captured gender, dietary profile, self-rated severity of gut health issues, regularly experienced symptoms, the perceived systemic impact of gut health on multiple dimensions of wellbeing, the relationship between anxiety and gut symptoms, psychological and social consequences, motivations for improving gut health, food intolerances, dietary triggers, IBS status, treatments tried and their effectiveness, and engagement with healthcare professionals.
Of 811 respondents, 86.7% (n=703) were female and 13.1% (n=106) male. The mean age was 54.2 years (median 54, range 19–100), with the majority aged 45–54 (37.7%) or 55 and over (46.8%). Diet was predominantly omnivorous (54.1%), with 12.1% flexitarian, 12.1% vegan, 9.4% vegetarian, and 5.8% pescatarian. Most respondents reported meaningful gut health difficulties: 10.9% described extreme or severe gut health issues, 46.1% regular issues, and 35.0% occasional issues. Only 8.0% reported no gut health issues at all.
Of 715 respondents, bloating was by far the most prevalent complaint (81.0%, n=579). The symptom burden was substantial: the mean number of symptoms per respondent was 6.2 (median 6), with 41.1% reporting seven or more distinct symptoms simultaneously. See Figure 1 for the full symptom prevalence profile.
| Symptom | Prevalence (n=715) | n |
|---|---|---|
| Bloating | 81.0% | 579 |
| Fatigue | 61.7% | 441 |
| Excessive wind or gas | 51.9% | 371 |
| Difficulty sleeping / insomnia | 51.2% | 366 |
| Weight gain | 47.7% | 341 |
| Constipation | 44.2% | 316 |
| Low moods and anxiety | 43.2% | 309 |
| Muscle aches | 39.9% | 285 |
| Diarrhoea | 32.7% | 234 |
| Skin health issues | 32.7% | 233 |
| Acid reflux | 32.4% | 232 |
| Urgency to use the toilet | 28.4% | 203 |
| Stomach cramps | 27.1% | 194 |
| Heartburn | 19.2% | 137 |
| Heart palpitations | 17.5% | 125 |
| Nausea | 14.1% | 101 |
| Pelvic pain | 13.3% | 95 |
Of 712 respondents, 97.2% reported that gut health had a direct impact on at least one other dimension of their wellbeing. See Figure 2 for the full systemic impact profile.
| Dimension of wellbeing affected | % reporting impact | n (of 712) |
|---|---|---|
| Energy | 78.9% | 562 |
| Weight | 69.7% | 496 |
| Mood | 63.5% | 452 |
| Stress and anxiety | 56.3% | 401 |
| Sleep | 50.6% | 360 |
| Focus and concentration | 37.4% | 266 |
| Skin health | 32.7% | 233 |
| Sex drive | 24.9% | 177 |
| Hair | 23.3% | 166 |
Of 715 respondents, 67.0% (n=479) reported that their gut health symptoms became worse when they were anxious, with only 12.0% reporting no such relationship and 21.0% being unsure. This strong bidirectional association between gut symptoms and anxiety, consistent with the established gut-brain axis, highlights that effective gut health management cannot be separated from psychological wellbeing.
Gut health symptoms generated substantial psychosocial burden. Of 712 respondents, 83.1% reported at least one psychosocial consequence. See Figure 3 for the full psychosocial consequence profile.
| Psychosocial consequence | % reporting (n=712) | n |
|---|---|---|
| Feeling fed up | 58.3% | 415 |
| Symptoms restricting daily life | 46.2% | 329 |
| Avoiding social contact / not wanting to go out | 39.2% | 279 |
| Mild depression | 30.5% | 217 |
| Not wanting to work | 20.2% | 144 |
| Feeling incapable | 12.5% | 89 |
| Severe depression | 6.3% | 45 |
Of 685 respondents, 45.3% identified at least one food intolerance, with dairy (21.3%), wheat (17.4%), gluten (16.4%), and lactose (12.3%) most commonly reported. Of 687 respondents, 91.6% identified at least one dietary trigger, with refined bread (55.6%), alcohol (35.2%), and milk and dairy (32.2%) most frequently cited.
Of 690 respondents, 25.9% (n=179) had a formal IBS diagnosis and 17.4% (n=120) were confident they had IBS without a formal diagnosis – giving a combined probable IBS prevalence of 43.3%. A further 24.3% were unsure, and only 30.3% were confident they did not have IBS.
Of 690 respondents, 93.0% had tried at least one strategy to address their gut symptoms. See Figure 4 for strategies tried and effectiveness ratings.
| Treatment strategy | % tried | % very / somewhat effective |
|---|---|---|
| Avoiding specific foods or drinks | 67.1% | 87.7% |
| Probiotic supplements | 65.9% | 80.3% |
| Elimination diet | 34.9% | 84.2% |
| Medication | 31.3% | 79.3% |
| Digestive enzyme supplements | 26.4% | 75.7% |
Of 682 respondents, 63.5% had seen a healthcare professional about their gut symptoms, most commonly a GP (56.7%). Service quality was rated as only excellent or good by 49.1% of those who had seen someone, with 35.9% rating it average and 15.1% poor or very poor. The leading motivations for investing in gut health were reducing bloating (77.3%), having more energy (67.3%), losing weight (51.4%), improving body confidence (46.4%), and improving sleep (44.5%).
This large survey of 811 adults demonstrates that gut health symptoms impose a high, multi-symptom burden (mean 6.2 symptoms per respondent); affect nearly every dimension of wellbeing, including energy, mood, sleep, and concentration; and generate substantial psychosocial consequences, including social withdrawal, depression, and reduced work capacity. The strong relationship between anxiety and gut symptoms (67.0%) confirms the clinical relevance of the gut-brain axis for this population. Existing management strategies provide only partial relief, with no treatment achieving very effective ratings in more than one in five users. These findings demonstrate a significant unmet need for effective, accessible, non-pharmacological interventions for gut health.
Keywords: gut health, IBS, bloating, fatigue, gut-brain axis, anxiety, psychosocial impact, probiotic supplements, food intolerances, women’s health
Survey date: 2022 | Sample size: N = 811 | Data: Individual-level responses
Media enquiries: Please contact [email protected]
Subtotal
£0.00
Shipping and taxes calculated at checkout.